| Detected | Trial | Change |
|---|---|---|
| 2026-06-04 | NCT07359040 Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell… |
overall status: "Active Not Recruiting" → "Recruiting" |
| 2026-06-03 | NCT07564518 Application of FreeStyle Libre 2 for Evaluating Glycemic Variability Characteristics in… |
Primary endpoint(s) modified |
| 2026-05-30 | NCT07517484 Light and Anesthesia |
date change Primary completion pushed: 2026-05-01 -> 2026-06-30 |
| 2026-05-30 | NCT07517484 Light and Anesthesia |
date change Completion pushed: 2026-05-01 -> 2026-06-30 |
| 2026-05-27 | NCT07588594 Thiotepa-Containing Conditioning Regimen for Allogeneic HSCT in Chronic Myelomonocytic… |
Phase changed: ['PHASE4'] -> ['NA'] |
| 2026-05-27 | NCT07588594 Thiotepa-Containing Conditioning Regimen for Allogeneic HSCT in Chronic Myelomonocytic… |
Sponsor changed: Sun Yuqian -> Peking University People's Hospital |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-11 | NCT07640997 Real-world Study of Aflibercept 8 mg in nAMD | Recruiting | |
| 2026-06-08 | NCT07632664 Clinical Study of a New Treatment Model for Elderly Lung Cancer Patients | Recruiting | |
| 2026-06-05 | NCT07629947 Peripheral Blood Versus Bone Marrow Plus Peripheral Blood Grafts for Haploidentical… | Not Yet Recruiting | |
| 2026-06-02 | NCT07620431 Neoadjuvant Radiotherapy and Surgery for High-Risk Localized Ewing Sarcoma | Not Yet Recruiting | |
| 2026-06-01 | NCT07617285 Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML | Phase 1 | Recruiting |
| 2026-06-01 | NCT07617740 IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE) | Early Phase 1 | Recruiting |
| 2026-05-20 | NCT07598084 Non-Contrast Breast MRI Diagnosis and Risk Stratification Using DWI-Generated Synthetic… | Not Yet Recruiting | |
| 2026-05-20 | NCT07600164 Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer | Phase 4 | Not Yet Recruiting |
| 2026-05-19 | NCT07597395 ATRA for Management of Primary ITP | Phase 3 | Not Yet Recruiting |
| 2026-05-18 | NCT07593365 Clinical Application of Vagus Nerve Stimulation Combined With Immunoregulatory T Cells in… | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07600164 | Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer | HER2 + Breast Cancer | Not Yet Recruiting |
| Phase 3 | |||
| NCT07441291 | CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT | B ALL | Recruiting |
| NCT07407660 | Shortened Venetoclax Duration Based on Day 14 BM Blasts Versus Standard Therapy in… | Acute Myeloid Leukemia | Not Yet Recruiting |
| NCT07597395 | ATRA for Management of Primary ITP | Immune Thrombocytopenia | Not Yet Recruiting |
| Phase 2 | |||
| NCT06970912 | ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in… | Hormone Receptor-Positive Breast Cancer | Recruiting |
| NCT07586813 | Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia… | Persistent Isolated Chemotherapy-Induced Thrombocytopenia | Recruiting |
| NCT07586826 | Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia… | Persistent Isolated Chemotherapy-Induced Thrombocytopenia | Recruiting |
| NCT07335887 | Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With… | AL Amyloidosis (AL) | Not Yet Recruiting |
| NCT07366112 | CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment | Hormone Receptor-Positive Breast Cancer | Not Yet Recruiting |
| NCT07449286 | IFN-α in Relapse Prevention. | Acute Myeloid Leukemia | Not Yet Recruiting |
| NCT07550582 | Mesenteric Vascular Preconditioning Combined With Laparoscopic and Endoscopic Cooperative… | Submucosal Tumor of Gastrointestinal Tract | Enrolling by Invitation |
| Phase 1/2 | |||
| NCT07479732 | Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma | Osteosarcoma | Recruiting |
| NCT06880913 | Nanobody-Based CD19/CD22 Tandem Dual CAR-T Therapy for R/R B-ALL | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Recruiting |
| NCT06874946 | Nanobody-Based Anti-CD5 CAR-T for Relapsed/Refractory T-ALL/NHL | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Recruiting |
| NCT07535645 | Baricitinib for Post-HSCT Persistent Thrombocytopenia | Persistent Thrombocytopenia | Not Yet Recruiting |
| Phase 1 | |||
| NCT07617285 | Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML | AML | Recruiting |
| NCT07315373 | Optimal Dose of Zanubrutinib to Treat Adult Immune Thrombocytopenia | Immune Thrombocytopenia | Not Yet Recruiting |
| Early Phase 1 | |||
| NCT07328711 | Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B | Chronic Hepaititis B | Recruiting |
| NCT07344818 | An Open and Dose-escalation Early Clinical Study of CD19 and CD20 CAR-T Cell Therapy for… | R/R Aggressive B-cell Lymphoma | Recruiting |
| NCT07617740 | IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE) | REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS | Recruiting |
| NCT07574346 | IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies | Malignancies | Not Yet Recruiting |
| Not specified | |||
| NCT06452732 | Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia… | Acute Myeloid Leukemia | Recruiting |
| NCT07318727 | Comparative Study on the Effect of Diet Interventions on Weight Loss in Overweight… | Endometrium Cancer | Recruiting |
| NCT07349498 | Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell… | Hematopoietic Stem Cell Transplantation | Recruiting |
| NCT06569095 | Predictive Value of Myelodysplastic Syndrome Stem Cells Determined by Multiparameter Flow… | Myelodysplastic Syndromes | Recruiting |